Tagged with OP

Korea Jong-Gu Chung, general manager of CooperVision Korea, lifts the lid on his strategy to establish their position in the Korean market for contact lenses. Chung also gives his assessment of the impact price-driven competition for lenses is having on the market, both for providers and users, and offers his ambition…

France Jaques Chevallet, CEO of Arkopharma, a European leader in herbal medicines and dietary supplements, discusses the company’s development over recent years while sharing his assessment on the current condition of the natural health product market and the role it can play as a partner to preventative care and healthcare sustainability.…

Opinion Meghann Chilcott, Chief Technology/Marketing Officer at Benzer Pharmacy charts out new pathways for improving the customer experience and sustaining business success through data-driven decision-making in support of independent pharmacists.   Patients of all ages are showing a greater desire for instant-access to healthcare information—something the digital transformation has made possible…

Opinion Jan Hux, the president and CEO of Diabetes Canada calls for governments to place greater importance on partnerships with patient groups for the making of big decisions in healthcare.    The establishment of a multi-stakeholder group, including patient organizations and patient representatives, could provide feedback and public policy recommendations to…

Opinion Richie Etwaru, Human Data Ethicist, and CEO of Hu-manity.co issues a warning to the pharmaceutical industry: Build trust with the consumer and change the narrative of public perception, before it is too late.   There is a ¼ trillion-dollar torpedo pointing at Pharma’s biggest weakness, the pharma industry never had…

Opinion Kevin Rufang Huang is the president and founder of the Chinese Organization for Rare Disorders (CORD). A rare disease patient himself, he is responsible for bringing“International Rare Disease Day” to China. Consequently, rare diseases now have much more visibility in the country. As an expert on the subject, Kevin breaks…

Opinion Drug development in rare diseases is currently in a very exciting time. While much of the focus is on the scientific advances,  access to rare disease patients and well-designed clinical trials are also essential to evaluating new therapeutics. In this article, PJ Brooks, Program Director at the Office of Rare…

China What do executive recruitment firms look for when hiring country managers for multinational pharma companies in some of the world’s most challenging markets? Eric Bouteiller and Simon Wan of  Cornerstone International Group outline what they look for in potential candidates for country manager positions in China.   The Ideal China…

India Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s ambitious healthcare insurance scheme, “Modicare” and delves into some of its critical challenges and associated opportunities for private players.   In theory, India’s states will be able to fine tune Modicare’s implementation to meet their…

Opinion On International Women’s Day 2019, David H. Crean, managing director for Objective Capital Partners, highlights the progress that has been made to close the gender investment gap, touching on key trends and biases in venture capital funding and outlining why investing in women matters.   When women business owners pitch their…

Opinion Technology and social media has given women and oppressed minorities a platform in which to vent their frustrations regarding the prevalent inequalities that exist in our world today, and it is having an impact. However, the needle is moving slowly and the gender gap continues to cost economies billions of dollars…

Opinion On International Women’s Day 2019, EFPIA Director General Nathalie Moll outlines how far women in life sciences have come in terms of both representation and perception and highlights four actions that industry professionals can take today to drive further change. Equality is giving everyone the same thing, equity is giving…